| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |